Flu infects thousands in Massachusetts
The worst flu season in 15 years has left hundreds of thousands of Americans hospitalized while straining physicians' offices and emergency departments.
Why it matters: The virus is causing more severe complications and hitting young children especially hard.
Driving the news: The U.S. is seeing a "high-severity" season, with estimates of at least 29 million cases, according to the latest Centers for Disease Control and Prevention data.
That's the highest number since the 2009-10 flu season.
By the numbers: Massachusetts has reported more than 48,000 flu cases since October, per state data.
At least 16,000 people nationwide have died from the flu as of Feb. 8, including 139 people from Massachusetts, per the CDC and state data.
Threat level: The two predominant strains circulating are known to be more severe, especially in high-risk patients, says Carol McLay, president of the Association for Professionals in Infection Control and Epidemiology.
"It's really clogging up our ERs and our outpatient facilities. And for the first time, we've seen cases of influenza that have surpassed COVID-19 in hospitalizations and deaths, since the COVID pandemic began," she said.
The spread has raised concerns about the impact on children. At least 68 children have died from the flu, including six children in Massachusetts.
Pediatric flu deaths hit a record 200 last year, and this season is shaping up to be worse, said Matthew Cook, president and CEO of the Children's Hospital Association.
There have also been reports of a limited number of pediatric cases with serious neurological complications associated with the flu.
Between the lines: This flu season may be made more severe because rates of seasonal flu vaccination have been falling in recent years for some groups, including children.
Compounding the problem is the fact that this year's flu vaccine was a bit less effective (35%) than in a typical year (45%).
People have also had much less exposure to flu in recent years amid the COVID-19 pandemic.
"We think because people were social distancing and using masks for so long during COVID that we have reduced immunity to it," McLay said.
What we're watching: Public health officials say they are increasingly flying blind since they can't interact with or get flu data from global sharing platforms FluNet and FluID after the Trump administration announced the U.S. exit from the World Health Organization.
That also has ramifications for next year's vaccine, since the global body helps determine the composition of seasonal shots.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
19 minutes ago
- Medscape
Year-Long Methotrexate Not Helpful for Inflammatory Knee OA
Compared with placebo, low-dose methotrexate administered weekly at doses up to 15 mg for 52 weeks did not relieve knee pain or reduce the size of effusion-synovitis in patients with inflammatory knee osteoarthritis (OA). METHODOLOGY: Researchers in China conducted a multicenter, clinical trial between July 2019 and January 2023 to examine whether low-dose methotrexate can reduce knee pain and effusion-synovitis in knee OA. They included 215 patients (mean age, 60.6 years; 89% women) with inflammatory knee OA and effusion-synovitis who were randomly assigned to receive either methotrexate or placebo, with weekly 5 mg folic acid supplementation given 1 day after treatment. Participants continued their regular medications (except corticosteroids and anti-synovitis drugs), did not take trimethoprim, and avoided alcohol during the trial. Primary outcomes were changes in knee pain on the visual analog scale (VAS) and inflammation measured by the effusion-synovitis maximal area on MRI over 52 weeks. Secondary outcomes were assessment of pain, stiffness, and physical function; changes in infrapatellar fat pad signal intensity; and evaluation of response to the assigned treatment. TAKEAWAY: At week 52, no significant difference was found between methotrexate and placebo groups in terms of VAS pain and effusion-synovitis maximal area (between-group difference, 0.3 mm; 95% CI, -6.7 to 7.3 mm and 0.1 cm 2 ; 95% CI, -0.8 to 1.0 cm 2 , respectively). ; 95% CI, -0.8 to 1.0 cm , respectively). No significant differences were observed between the two groups in terms of any of the prespecified secondary outcomes. The frequency of experiencing at least one adverse event was comparable between the methotrexate and placebo groups (29.6% and 24.3%, respectively); however, elevated concentrations of liver enzymes were more common in the methotrexate group. IN PRACTICE: 'Given the lack of efficacy of MTX [methotrexate] across knee OA studies and the known potential adverse events, it is not recommended for the treatment of painful, inflammatory knee OA. We now need to focus our attention on treatments that can both inhibit joint inflammation and stimulate chondrocytes within the cartilage to synthesize replacement matrix. The future of pharmaceuticals for knee OA needs to move past MTX,' Nancy E. Lane, MD, UC Davis Health, Sacramento, California, wrote in an accompanying editorial. SOURCE: This study was led by Zhaohua Zhu, PhD, Zhujiang Hospital, Southern Medical University, Guangzhou, China. It was published online on June 2, 2025, in JAMA Internal Medicine . LIMITATIONS: This study was conducted during COVID-19 shutdowns, which delayed recruitment and potentially increased loss to follow-up and nonadherence rates. The findings may not be fully generalizable because most participants were women, and racial and ethnic diversity was limited. The relatively small number of participants in each subgroup may have limited the ability to detect significant benefits in specific populations. DISCLOSURES: This study received funding from the National Key Research and Development Program of China, the National Natural Science Foundation of China, and the Clinical Research Startup Program of Southern Medical University. One author reported providing consulting advice on scientific advisory boards for various pharmaceutical companies outside the submitted work.
Yahoo
an hour ago
- Yahoo
When it comes to liberty, Florida, why stop at fluoride?
Our state legislature's ban on fluoridation does not go far enough. When Republican State Rep. Danny Alvarez said, "This is not about fluoride. This is about your liberty," every word applied to chlorine with equal relevancy. Yes, chlorine. The chemical that makes swimming pools smell funny as it neutralizes the indiscretions of bathers. How dare the government add chlorine to our drinking water to protect us from diseases such as cholera, dysentery, and typhoid without our consent! Some of us might prefer seeking "herd immunity" to these illnesses, even though untrustworthy "science" tells us this is impossible. Remember, this "science" also alleges we are in "climate change," an untruth our governor has banned from our textbooks and legislation. Ending chlorination isn't a blue issue or a red issue; it's a green issue. Let's turn our tap water green with algae and pond scum as a perpetual reminder that we are free Americans living in the Free State of Florida. Fluoridation in Florida: City-by-city: Does your municipality use fluoride to treat its drinking water? Carl Imboden, West Palm Beach This article originally appeared on Palm Beach Post: Florida got freedom from fluoride. They shouldn't stop there | Letters
Yahoo
an hour ago
- Yahoo
Groups begin lobbying N.S. government over potential booze sale changes
With the provincial government launching consultation on whether to expand sales points for alcohol in Nova Scotia, interested parties are not waiting for a phone call. Organizations on both sides of the issue have started issuing news releases and open letters to Finance Minister John Lohr, whose department is overseeing the process. Lohr announced last week that Infuse Public Relations and Crestview Strategy will collectively manage the public opinion polling of 1,500 random people and stakeholder engagement with 194 groups. The contract for the work is worth $300,000. A news release this week from the Atlantic division of the Canadian Federation of Independent Business said 77 per cent of small businesses in Nova Scotia support allowing convenience stores and grocery stores to sell alcohol. "This moment is the government's chance to support local retailers at a time when over six in 10 are experiencing lower demand, and provide much-needed shelf space to local producers," Duncan Robertson, the federation's director of legislative affairs, said in the release. The CFIB's recommendations include allowing the sale of beverages that do not exceed alcohol by volume of 7.1 per cent in convenience and grocery stores — similar to steps taken in Ontario — and opening those rules to all small businesses, not just large retailers. Nova Scotia already permits alcohol to be sold in some private wine and specialty stores, in on-site stores at breweries and wineries, and farmers' markets. Lohr also received an open letter this week from a group of 14 doctors who specialize in addiction medicine, urging the government not to expand alcohol sales because it would increase consumption and "worsen individual and societal harms." "Every day we care for patients and families suffering from alcohol use disorder and medical complications of alcohol use," the letter said. "Alcohol causes more than 500 deaths, 5,000 hospital admissions, and 35,000 emergency department visits in Nova Scotia each year, and creates more health care and social costs to our province than any other substance." The doctors went on to say that revenue earned through taxation on alcohol sales does not compensate for society-wide costs of health harms, violence and driving accidents attributable to alcohol. They wrote that alcohol is already widely available in Nova Scotia Liquor Corporation retail and agency stores. "It is crucial that the government keeps control of alcohol distribution to minimize further public costs and health harms," they said. Finance Department officials said 194 groups are included in stakeholder engagement so far. That includes 126 craft breweries, wineries and distillers, along with another 11 groups or agencies also in favour of opening things up, such as the Retail Council of Canada. Jim Cormier, the group's Atlantic director of government relations, said members have been looking at this issue particularly since the COVID-19 pandemic. "They've been looking at any way to try and get more people to get away from online shopping, using their smartphones to shop, and get them to come out to go into bricks-and-mortar stores," he said in an interview. Cormier said there can be extended benefits for the local economy by getting people into retail stores where it's possible to cross-promote Nova Scotia craft beer, wine and spirits with other products, such as cheese, berries and glassware. "Obviously it would be more than just Nova Scotia products, but that's the pitch we're making," he said. Council members are looking for things to be as open as possible so there are no winners or losers, said Cormier. "If you're in a rural community and there happens to be a hardware store and they think that they could make a case that they could sell beer and do so in a responsible manner and meet all the rules and regulations, why shouldn't they be allowed to at least apply to do that?" Dr. Kirstin Weerdenburg, a pediatric emergency physician and a trauma team leader at the IWK Health Centre, said it is vital that the government not make any changes without first speaking to the people responsible for caring for those most impacted by alcohol. During her 10 years working in Nova Scotia since moving from Ontario where she also practised medicine, Weerdenburg said she's seen an increase in the number of young people presenting to the emergency department with intoxication. Data needs to be reviewed under the current regulatory regime to understand what's happening before access is expanded, she said. "I do start to get more concerned nowadays, if kids have more access, what their futures will look like." Weerdenburg is also a member of the Nova Scotia Alcohol Policy Coalition, which recently wrote to the government outlining its concerns. The group is one of several dozen representing interests related to health care, intimate partner violence prevention, addictions and marginalized communities slated to be consulted. Although the stakeholder list does not include Nova Scotia Health, the IWK Health Centre or Public Health, a Finance Department spokesperson said the three agencies would be consulted as part of an internal engagement process for government departments. MORE TOP STORIES
